CompletedNot Applicable

Gout Self-Monitoring Aiming to Reach Target

United Kingdom60 participantsStarted 2019-04-05

Plain-language summary

This study evaluates whether a supported self-management approach to gout is able to achieve target levels of serum urate, and better control of gout flares.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed diagnosis of gout (as per American College of Rheumatology criteria) * Physician recommendation that escalation of urate lowering therapy with allopurinol or febuxostat is appropriate. * Serum urate \>0.36mm/L. * Patient has a mobile phone and is able to install GoutSMART (Gout Self-monitoring Aiming to Reach Target urate) application. Exclusion Criteria: * Subject is unable to provide consent * Severe renal failure (eGFR \<30) or established liver disease * Previous adverse reaction to allopurinol or febuxostat

What they're measuring

Percentage of Participants Achieving Target Urate Levels (24 Weeks)

Timeframe: 24 weeks

Trial details

NCT IDNCT03274063

SponsorUniversity of Edinburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-03-19

Results submitted2022-05-08

View on ClinicalTrials.gov More Gout trials